Jeppesen, U. N. http://orcid.org/0000-0002-9481-1554
Due, A. S.
Mariegaard, L.
Pinkham, A.
Vos, M.
Veling, W.
Nordentoft, M.
Glenthøj, L. B.
Funding for this research was provided by:
TrygFonden (148727)
Danmarks Frie Forskningsfond (0134-00066B)
Region Hovedstaden (A6622)
Article History
Received: 5 December 2022
Accepted: 3 January 2023
First Online: 23 January 2023
Declarations
:
: All protocol amendments need to be approved by the Committee on Health Research Ethics of the Capital Region Denmark. Deviations from the published protocol will be documented on the trial registration on ClinicalTrials.gov (NCT04902066).The supplementary approval regarding changing the primary outcome, described above, was rejected, and we are therefore forced to keep ideas of persecution, part B in GPTS, as the primary outcome. This is also noted on ClinicalTrials.gov.
: Not applicable.
: The authors declare that they have no competing interests.